Cardiovascular disease and inflammation in Ugandan children with HIV

乌干达艾滋病毒感染者的心血管疾病和炎症

• 批准号: 9752647
• 负责人: Sahera Dirajlal-Fargo
• 金额: $ 16.73万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-25 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9752647
• 关键词: Adolescent; Adult; Africa South of the Sahara; Age; Bacterial Translocation; Biological Markers; Birth; Cardiac; Cardiovascular Diseases; Cardiovascular Physiology; Cardiovascular system; Child; Childhood; Chronic; Clinical Research; Communicable Diseases; Comorbidity; Data; Disease; Disease Marker; Disease Resistance; Ensure; Exposure to; Face; FarGo; Funding; Future; Gastrointestinal tract structure; Gender; HIV; HIV Infections; HIV antiretroviral; HIV therapy; Health; Heart Diseases; High Prevalence; Homeostasis; Immunology; Individual; Inflammation; Inflammatory; Insulin Resistance; International; Intervention; Knowledge; Life; Link; Longitudinal Studies; Longitudinal cohort; Measures; Mentors; Mentorship; Metabolic; Modeling; Mucous Membrane; Nutritional; Outcome; Participant; Patients; Pediatric Hospitals; Pharmaceutical Preparations; Physiologic pulse; Play; Population; Population Control; Prevention strategy; Research; Research Design; Research Personnel; Resources; Risk; Risk Factors; Risk Reduction; Role; Science; Surrogate Markers; Testing; Time; Training; Uganda; Universities; Vascular Diseases; Youth; antiretroviral therapy; cardiometabolic risk; cardiometabolism; cardiovascular disorder risk; cardiovascular imaging; cardiovascular risk factor; carotid intima-media thickness; clinical care; clinically significant; co-infection; cohort; experience; high risk; immune activation; immune function; improved; indexing; inflammatory marker; microbial; monocyte; novel; pediatric department; pediatric human immunodeficiency virus; pediatric patients; programs; restoration; sex; statistics; virology

Project Summary/Abstract: Adults with HIV are at increased risk of cardiovascular and metabolic complications compared to HIV-uninfected control populations. Compared to what is known in adults, little is known about these risks in the pediatric population and even less in the setting of sub-Saharan Africa. Although inflammation has been linked to cardiovascular disease in adults with HIV, the role of inflammation on markers of cardiovascular disease risk has been scarcely investigated in HIV-infected children and adolescents. Furthermore, the impact of non-AIDS co morbidities may be greater in sub-Saharan Africa, though no studies of CVD have been conducted in children on ART in this setting. The overall objective of this proposed K23 research plan is to use surrogate markers of cardiovascular disease to identify HIV-infected children and youth at risk of early heart disease and to understand the mechanisms of these changes, so that risk- reduction therapies can be appropriately targeted and novel preventive strategies may be developed in the future. In a longitudinal study of 100 HIV-infected youth and 100 healthy controls, this project aims to use carotid intima media thickness (cIMT), pulse wave velocity (PWV) and insulin resistance to identify early cardiometabolic risks in HIV- infected youth compared to age and gender match HIV uninfected controls in Kampala, Uganda. Additionally, we will investigate whether these makers of cardiometabolic disease correlate with biomarkers of inflammation and gut integrity. This study will provide a comprehensive view of how inflammation, immune activation and bacterial translocation relate to cardiometabolic disease among HIV-infected children and adolescents. The PI, Dr Dirajlal-Fargo, is an exceptional candidate who is seeking to become an internationally recognized clinician-investigator in the field of cardiometabolic complications in pediatric HIV. She also has experience conducting clinical research in Uganda. Dr Dirajlal-Fargo has strong institutional support from Case Western Reserve University and the Department of Pediatrics at Rainbow Babies and Children's Hospital. She will have guaranteed 75% protected research time and access to a wealth of resources that will ensure a successful transition to independently funded investigator. Her robust training plan includes: 1)high quality mentorship from her primary mentor, Dr Grace McComsey, as well as co-mentors in the field of immunology, infectious disease and cardiovascular complications of HIV and pediatric HIV in Uganda, a biostatistician and a group of collaborators; 2) coursework in fundamental immunology with a focus on chronic HIV infection; 3) training in cardiovascular imaging and physiology; 4) training in clinical research design and statistics; 5) experience in international interdisciplinary team science; and 6) field experience in integrating clinical care and research programs.

项目总结/文摘: